Oct 28-29: The Fed's Next Move Could Crush the Dollar
The Fed just cut rates by 0.25% - but this is no relief. It's the start of a dangerous cycle that could crush the dollar. With another Fed meeting looming Oct. 28-29, smart investors are already moving. See 3 urgent steps to protect yourself before it's too late.
Skye Bioscience Advances Position In Competitive Obesity Market With Promising Data
Skye Bioscience's latest data show nimacimab boosted tirzepatide's weight loss effects and reduced obesity treatment rebound risk.
Republican leaders reject Democratic health care demands for bill to avoid shutdown
WASHINGTON (AP) — Republican leaders in the House and Senate said Wednesday that they will reject for an immediate , challenging Democrats to vote against a stopgap spending bill that doesn't include them but will keep the government open at the end of the month.
We've Seen This Before... and It Didn't End Well - Ad
Strange events are unfolding in the global financial system. A monetary reset dubbed the "Mar-a-Lago Accord" is quietly in motion, and the financial elite are already taking protective action. If history is any guide, you could lose up to 40% of your wealth in the next two years. Move your money before it's too late.
Plus Therapeutics Announces National Coverage Agreement with UnitedHealthcare For CNS Cancer Diagnostic Kit
CNSide Diagnostics, a wholly-owned subsidiary of Plus Therapeutics, Inc. (NASDAQ: PSTV), has signed a national agreement with UnitedHealthcare insurance company, a unit of UnitedHealth Group Inc. (NYSE:
Indigenous groups criticize Ecuador’s $47 billion oil expansion plan in Amazon
BOGOTA, Colombia (AP) — Seven Indigenous groups in Ecuador’s Amazon have denounced a government plan to offer dozens of blocks of land for oil exploration, saying it threatens their ancestral lands and violates constitutional protections.
Why Wall Street Is Positioning for a Fallout - Ad
Something far more consequential for your money than tariffs is unfolding behind the scenes... Tucked inside this overlooked directive is a plan set to be executed for the first time in in U.S. history. One Stansberry Research's Senior Partner says it's set to trigger a rare window for potentially explosive gains in ONE asset immediately. (Not AI or crypto). Wall Street insiders are already positioning themselves... and he insists you should, too, before it's too late.
Trump's touting of an unproven autism drug surprised many, including the doctor who proposed it
WASHINGTON (AP) — When President Donald Trump's administration announced it would as a new treatment for autism, it came as — including the physician who suggested the idea to the nation’s top health officials.
State of Connecticut settles lawsuit over convict's killing of visiting nurse for $2 million
HARTFORD, Conn. (AP) — Connecticut officials have agreed to a $2.25 million settlement of a lawsuit over a sex offender's killing of visiting nurse Joyce Grayson at a halfway house in 2023 — a case that for home health care workers across the country.
Elon's $25 Trillion Confession - Ad
Elon Musk: "Tesla will become a $25 trillion company." That would make Tesla 8x bigger than Apple today. How is that possible? He admits it's all thanks to this one AI breakthrough that will take AI out of our computer screens and manifest a 250x boom here in the real world.
Tylenol maker rebounds a day after Trump's unfounded claims about its safety
Shares of Tylenol maker Kenvue bounced back sharply before the opening bell a day after President Donald Trump promoted between Tylenol, vaccines and autism.
FDA Clears Merck's One-Minute Cancer Shot
FDA approves Merck's Keytruda Qlex injection for adults with solid tumors. Merck expects it to be available in the U.S. in September.
Alabama Just Took Equity in a Retail Underdog - Ad
The Univ. of Alabama Athletics program is backing a tiny Nasdaq company-one that's rewriting the playbook. The last retail underdog to move like this? Fanatics and their $31B valuation.
Johnson & Johnson's Tecvayli-Darzalex Combo Shows 100% Response In Newly Diagnosed Myeloma Patients
Johnson & Johnson's Tecvayli-Darzalex regimen showed 100% response rates and high MRD negativity in newly diagnosed multiple myeloma patients.
A robot programmed to act like a 7-year-old girl works to combat fear and loneliness in hospitals
Days after Meagan Brazil-Sheehan’s 6-year-old son was diagnosed with leukemia, they were walking down the halls of UMass Memorial Children’s Medical Center when they ran into Robin the Robot.
Powell Strikes Again - Next Rate Shock Looms October 28-29 - Ad
The Fed just cut rates by 0.25% - but this is no relief. It's the start of a dangerous cycle that could crush the dollar. With another Fed meeting looming Oct. 28-29, smart investors are already moving. See 3 urgent steps to protect yourself before it's too late.
FDA proposes ban on Orange B, a food dye not used for decades
Federal regulators are proposing to remove another from the U.S. food supply — Orange B, a synthetic color that hasn't been used in the U.S. for decades.
Amazon spends $1 billion to increase pay and lower health care costs for US workers
NEW YORK (AP) — Amazon says it's making a $1 billion investment to raise wages and lower the cost of health care plans for its U.S. fulfillment and transportation workers.
Oct 28-29: The Fed's Next Move Could Crush the Dollar - Ad
The Fed just cut rates by 0.25% - but this is no relief. It's the start of a dangerous cycle that could crush the dollar. With another Fed meeting looming Oct. 28-29, smart investors are already moving. See 3 urgent steps to protect yourself before it's too late.
UN report cites huge government corruption in South Sudan as its food crisis worsens
NAIROBI, Kenya (AP) — Billions of dollars in public funds in South Sudan have been stolen over the past decade in massive government corruption while the vast majority of the country suffers food insecurity, a U.N. commission said Tuesday.
New York's ban on addictive social media feeds for kids takes shape with proposed rules
New York’s attorney general on Monday proposed regulations for its crackdown on addictive social media feeds for children, including rules for verifying a user’s age.
[Revealed] Trump's Next AI Executive Orders? - Ad
A White House insider with direct ties to Trump's inner circle just revealed what he calls "Manhattan II" - a potential $2.2 trillion AI initiative set to launch as soon as Oct 15. He says this could mirror past U.S. projects that minted fortunes - with small firms soaring 5,000% to 10,000% over two decades. And now he's giving away his #1 stock pick for free before the deadline.
Hims & Hers Faces FDA Heat As Commissioner Martin Makary Calls Out Super Bowl Ad For Hiding Drug Risks
FDA Commissioner Martin Makary said Hims & Hers broke federal law with its Super Bowl ad promoting weight-loss drugs without disclosing side effects, and called it "the most overt breach" of FDA rules.
Silexion Therapeutics Shares Surge On Positive Preclinical Pancreatic Cancer Data
Silexion's SIL204 showed strong anti-tumor effects in preclinical tests, reaching major metastasis sites in pancreatic cancer models at human-relevant doses.
Silver Just Hit $41 and This Stock Is Still Under $10 - Ad
Thousands of silver explorers exist. Only a handful actually produce. One producer with 30M+ ounces a year is still under $10. Scarcity drives opportunity.
Ionis Pharmaceuticals To Expedite Development Of Rare Neurological Disease Candidate With FDA Breakthrough Status
FDA designates Ionis Breakthrough Therapy for Angelman syndrome after Phase 1/2 results showed functional improvements.
Large Patient Population Is Key Driver For Bright Minds' Growth
BTIG initiates coverage on Bright Minds Biosciences with a Buy rating, citing BMB‑101's potential and key Phase 2 data expected by the end of 2025
Fanatics Hit $31B. This Nasdaq Company Is Building the Next Wave - Ad
Fanatics built a merch empire by owning the fan experience. But a $50M Nasdaq disruptor is updating their strategy for the social media generation. and they just locked in a game-changing college deal. Could this be retail's next big run?
Regenxbio Unveils 12-Month Data For Gene Therapy Soon After FDA Delays Review Date
Regenxbio reported sustained biomarker reduction and positive neurodevelopmental outcomes in the pivotal CAMPSIITE trial of RGX-121 for MPS II.
These neurodivergent students are helping each other build more inclusive schools
DENVER (AP) — Engineering student Tory Ridgeway buried his head.
TikTok + Touchdowns = Momentum - Ad
NIL deals and social media clout are now driving merch sales into the billions. One Nasdaq disruptor is first to align with a football dynasty and a commerce giant.
Artelo Biosciences Drug Helps Cancer Patients Regain Weight, Eyes Licensing Deal
Artelo Biosciences reported encouraging Phase 2 trial results for ART27.13 in cancer anorexia-cachexia syndrome, citing strong partner interest.
Trump Admin 'Lying' And 'Fudging The Numbers' About Social Security Wait-Time Data, Says Elizabeth Warren
Senator Warren accuses Trump administration of lying about Social Security wait times and calls for an investigation instead of 'fudging the numbers'.
We've Seen This Before... and It Didn't End Well - Ad
Strange events are unfolding in the global financial system. A monetary reset dubbed the "Mar-a-Lago Accord" is quietly in motion, and the financial elite are already taking protective action. If history is any guide, you could lose up to 40% of your wealth in the next two years. Move your money before it's too late.
Robert Kennedy Jr.'s Leadership Can Only Bring More 'Harm,' Says Top Ex-CDC Official: 'Undoing Of Vaccination' In Works
Daskalakis resigned due to political interference in CDC, fears harm will come from new direction. CDC leaders also resign in protest.
Social Security whistleblower who claims DOGE mishandled Americans' sensitive data resigns from post
WASHINGTON (AP) — A Social Security official who has filed a whistleblower complaint alleging the Department of Government Efficiency officials Americans' sensitive information says he's resigning his post because of actions taken against him since making his complaint.
Why Wall Street Is Positioning for a Fallout - Ad
Something far more consequential for your money than tariffs is unfolding behind the scenes... Tucked inside this overlooked directive is a plan set to be executed for the first time in in U.S. history. One Stansberry Research's Senior Partner says it's set to trigger a rare window for potentially explosive gains in ONE asset immediately. (Not AI or crypto). Wall Street insiders are already positioning themselves... and he insists you should, too, before it's too late.
Stock Of The Day: Time To Buy Cooper Companies?
The Cooper Companies (COO) are oversold and at support. These dynamics can set the stage for a new uptrend to form.
Johnson & Johnson Ends Rheumatoid Arthritis Drug Combo Program
Johnson & Johnson ended a Phase 2a study of nipocalimab in rheumatoid arthritis after no added benefit was seen, but remains confident in its market potential.
Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.